A new benzodiazepine pharmacology - PubMed
Review
A new benzodiazepine pharmacology
H Möhler et al. J Pharmacol Exp Ther. 2002 Jan.
Abstract
Classical benzodiazepine drugs are in wide clinical use as anxiolytics, hypnotics, anticonvulsants, and muscle relaxants. They act by enhancing the gamma-aminobutyric acid(A) (GABA(A)) receptor function in the central nervous system. The pharmacological relevance of the multitude of structurally diverse GABA(A) receptor subtypes has only recently been identified. Based on an in vivo point mutation strategy, alpha(1)-GABA(A) receptors were found to mediate sedation, anterograde amnesia, and part of the seizure protection, whereas alpha(2)-GABA(A) receptors, but not alpha(3)-receptors, mediate anxiolysis. Rational drug targeting to specific receptor subtypes has now become possible. Only restricted neuronal networks will be modulated by the new subtype-selective drugs. Promising new anxiolytics have already been developed. A new pharmacology of the benzodiazepine site is on the horizon.
Similar articles
-
Pathophysiological aspects of diversity in neuronal inhibition: a new benzodiazepine pharmacology.
Möhler H. Möhler H. Dialogues Clin Neurosci. 2002 Sep;4(3):261-9. doi: 10.31887/DCNS.2002.4.3/hmoehler. Dialogues Clin Neurosci. 2002. PMID: 22034214 Free PMC article.
-
Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes.
Rudolph U, Crestani F, Benke D, Brünig I, Benson JA, Fritschy JM, Martin JR, Bluethmann H, Möhler H. Rudolph U, et al. Nature. 1999 Oct 21;401(6755):796-800. doi: 10.1038/44579. Nature. 1999. PMID: 10548105
-
Pathophysiology and pharmacology of GABA(A) receptors.
Möhler H, Fritschy JM, Vogt K, Crestani F, Rudolph U. Möhler H, et al. Handb Exp Pharmacol. 2005;(169):225-47. doi: 10.1007/3-540-28082-0_9. Handb Exp Pharmacol. 2005. PMID: 16594261
-
Ligands for the benzodiazepine binding site--a survey.
Teuber L, Wätjens F, Jensen LH. Teuber L, et al. Curr Pharm Des. 1999 May;5(5):317-43. Curr Pharm Des. 1999. PMID: 10213798 Review.
-
GABA-A receptors: a viable target for novel anxiolytics?
Whiting PJ. Whiting PJ. Curr Opin Pharmacol. 2006 Feb;6(1):24-9. doi: 10.1016/j.coph.2005.08.005. Epub 2005 Dec 15. Curr Opin Pharmacol. 2006. PMID: 16359919 Review.
Cited by
-
Search for α3β₂/₃γ2 subtype selective ligands that are stable on human liver microsomes.
Namjoshi OA, Wang ZJ, Rallapalli SK, Johnson EM Jr, Johnson YT, Ng H, Ramerstorfer J, Varagic Z, Sieghart W, Majumder S, Roth BL, Rowlett JK, Cook JM. Namjoshi OA, et al. Bioorg Med Chem. 2013 Jan 1;21(1):93-101. doi: 10.1016/j.bmc.2012.10.057. Epub 2012 Nov 15. Bioorg Med Chem. 2013. PMID: 23218469 Free PMC article.
-
Forman SA, Miller KW. Forman SA, et al. Anesth Analg. 2016 Nov;123(5):1263-1273. doi: 10.1213/ANE.0000000000001368. Anesth Analg. 2016. PMID: 27167687 Free PMC article. Review.
-
Nemoto C, Murakawa M, Hakozaki T, Imaizumi T, Isosu T, Obara S. Nemoto C, et al. J Anesth. 2013 Oct;27(5):771-4. doi: 10.1007/s00540-013-1589-5. Epub 2013 Mar 13. J Anesth. 2013. PMID: 23483299
-
Impairment of GABA inhibition in insomnia disorders: Evidence from the peripheral blood system.
Xiang T, Liao J, Cai Y, Fan M, Li C, Zhang X, Li H, Chen Y, Pan J. Xiang T, et al. Front Psychiatry. 2023 Feb 9;14:1134434. doi: 10.3389/fpsyt.2023.1134434. eCollection 2023. Front Psychiatry. 2023. PMID: 36846238 Free PMC article.
-
Mao R, Page DT, Merzlyak I, Kim C, Tecott LH, Janak PH, Rubenstein JL, Sur M. Mao R, et al. J Neurodev Disord. 2009 Sep;1(3):224-36. doi: 10.1007/s11689-009-9025-8. Epub 2009 Jul 11. J Neurodev Disord. 2009. PMID: 19816534 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources